CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,320,469
- in 18 filings, $12.5M under 10b5-1 plans
Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blum Robert I −$9.7M President & CEO sold 34% of stake
- Malik Fady Ibraham −$1.3M EVP Research & Development sold 12% of stake
- Hessekiel Jeffrey −$795K Chief Legal & Admin Officer sold 14% of stake
- Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
- PARSHALL B LYNNE −$631K Director sold 63% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-16 | Wong Robert VP, Chief Accounting Officer | Shares withheld for taxes | −510 | $44.13 | $23K | 27,023 |
| 2023-02-16 | Malik Fady Ibraham EVP Research & Development | Shares withheld for taxes | −1,513 | $44.13 | $67K | 150,926 |
| 2022-12-21 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +10,000 | $9.65 | $97K | 416,412 |
| 2022-12-21 | Blum Robert I President & CEO | Sale 10b5-1 | −10,000 | $43.92 | $439K | 406,412 |
| 2022-12-21 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −10,000 | 155,691 |
Page 45 of 45 · 885 trades